Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children ...
Originally Published: 04/22/2011
Post Date: 04/22/2011
Phase III Study in Progress by Purdue Pharma to establish efficacy and safety of Oxycontin for pain management in children 6-16.
See attached PDF for full study: Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids Purpose: The purpose of this study is to characterize the safety of oxycodone hydrochloride (HCl) controlled-release (CR) tablets in opioid tolerant pediatric patients aged 6 to 16 years, inclusive, with moderate to severe malignant and/or nonmalignant pain requiring opioid therapy. It is the policy of Choopers Guide to restrain from commenting on public policy however we have elected to make an exception and offer a few common sense comments on this clinical trial. Please see attached PDF -Increasing Market Share and Locking In Tomorrows Profits for commentary on this study.